Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Acenxion Biosystems logo — Phenotypic AST results, in hours.

Acenxion Biosystems

Phenotypic AST results, in hours.

Founded 2020 United States Kansas City, United States 11 employees Seed Total: $4.25M Biotechnology, Life Sciences

General Information

Company Name Acenxion Biosystems
Founded Year 2020
Location United States Kansas City, United States +1
Employees 11
Industries Biotechnology, Life Sciences
Funding Stage Seed
Social

Get notified when Acenxion Biosystems moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Acenxion Biosystems

Acenxion Biosystems is a biotechnology startup founded in 2020 in the United States. The company's focus is on providing phenotypic AST results in a matter of hours, a process that traditionally takes days. Their slogan, "Phenotypic AST results, in hours," highlights their commitment to efficiency in clinical workflows. The scalable and automated AST system offered by Acenxion seamlessly integrates into existing clinical procedures, enabling rapid targeted treatment and minimizing antibiotic exposure to AMR pressures. The latest milestone for Acenxion Biosystems is their recent Seed Round investment of $954.00K, completed on 01 December 2022. The infusion of capital is expected to support the company in further developing and commercializing their innovative AST system. In light of the pressing global issue of antimicrobial resistance (AMR), the significance of Acenxion's mission cannot be overstated. The need for rapid and accurate phenotypic AST results is acute, and Acenxion's solution has the potential to make a substantial impact in this critical area of healthcare. Their capacity to attract investor interest and funding is a testament to the potential seen in their technology and business model. As they continue on their growth trajectory, Acenxion Biosystems is poised to be a compelling player in the biotechnology industry.

Taxonomy: Antimicrobial Susceptibility Testing, Phenotypic AST, Bacterial Detection, Clinical Workflows, Automated Systems, Rapid Testing, AMR Pressures, Antibiotic Resistance, Patient Outcomes, Healthcare Costs, Antibiotic Exposure, Healthcare Innovation, Medical Diagnostics

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• - 01 Dec 2022
Grant •••••• 1 •••• •••• 11 Jan 2021
Seed Round •••••• 1
Investor
11 May 2020

Acenxion Biosystems Alternatives & Competitors

Acenxion Biosystems vs
Resistell
Resistell Switzerland

Our rapid AST will save lives by finding the right antibiotic on time and will reduce spreading of a...

Series B
26 employees
Medical Devices
Compare Acenxion Biosystems vs Resistell
Acenxion Biosystems vs
Avails Medical, Inc.
Avails Medical, Inc. United States

Avails Medical, Inc. - Affordable & Rapid Antibiotic Susceptibility Testing for clinical laboratorie...

Grant
51 employees
Health Care, Medical Devices
Compare Acenxion Biosystems vs Avails Medical, Inc.
Acenxion Biosystems vs
Gradientech
Gradientech Sweden

Precision medicine for a sustainable world.

Series Unknown
42 employees
Biotechnology, Health Care
Compare Acenxion Biosystems vs Gradientech

FAQ About Acenxion Biosystems

Phenotypic AST results, in hours.
Acenxion Biosystems was founded in 2020.
Acenxion Biosystems is headquartered in Kansas City, United States.
Acenxion Biosystems operates in the following industries: Biotechnology, Life Sciences.
Acenxion Biosystems has approximately 11 employees.
Acenxion Biosystems has completed 3 funding rounds, raising a total of $4.25M. The latest funding stage is Seed.
Top alternatives and competitors to Acenxion Biosystems include Resistell, Avails Medical, Inc., Gradientech, Pathnostics - A Diagnostics Solutions Company, Pattern Bioscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Acenxion Biosystems and Resistell are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Acenxion Biosystems and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy